vs

Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $18.7M, roughly 1.7× HEALTHY CHOICE WELLNESS CORP.). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -28.1%, a 19.2% gap on every dollar of revenue. HEALTHY CHOICE WELLNESS CORP. produced more free cash flow last quarter ($-927.1K vs $-2.3M).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

HCWC vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.7× larger
RXST
$32.6M
$18.7M
HCWC
Higher net margin
HCWC
HCWC
19.2% more per $
HCWC
-8.9%
-28.1%
RXST
More free cash flow
HCWC
HCWC
$1.3M more FCF
HCWC
$-927.1K
$-2.3M
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCWC
HCWC
RXST
RXST
Revenue
$18.7M
$32.6M
Net Profit
$-1.7M
$-9.2M
Gross Margin
39.1%
77.5%
Operating Margin
-7.6%
-34.8%
Net Margin
-8.9%
-28.1%
Revenue YoY
-18.9%
Net Profit YoY
-54.1%
EPS (diluted)
$-0.05
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCWC
HCWC
RXST
RXST
Q4 25
$18.7M
$32.6M
Q3 25
$19.0M
$30.3M
Q2 25
$20.2M
$33.6M
Q1 25
$20.3M
$37.9M
Q4 24
$40.2M
Q3 24
$18.2M
$35.3M
Q2 24
$34.9M
Q1 24
$29.5M
Net Profit
HCWC
HCWC
RXST
RXST
Q4 25
$-1.7M
$-9.2M
Q3 25
$-1.2M
$-9.8M
Q2 25
$-339.4K
$-11.8M
Q1 25
$-712.4K
$-8.2M
Q4 24
$-5.9M
Q3 24
$-2.7M
$-6.3M
Q2 24
$-6.1M
Q1 24
$-9.1M
Gross Margin
HCWC
HCWC
RXST
RXST
Q4 25
39.1%
77.5%
Q3 25
38.8%
79.9%
Q2 25
40.1%
74.9%
Q1 25
38.8%
74.8%
Q4 24
71.6%
Q3 24
38.4%
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
HCWC
HCWC
RXST
RXST
Q4 25
-7.6%
-34.8%
Q3 25
-3.2%
-40.1%
Q2 25
-0.2%
-41.6%
Q1 25
-2.0%
-28.2%
Q4 24
-21.5%
Q3 24
-2.0%
-26.1%
Q2 24
-23.9%
Q1 24
-36.2%
Net Margin
HCWC
HCWC
RXST
RXST
Q4 25
-8.9%
-28.1%
Q3 25
-6.4%
-32.4%
Q2 25
-1.7%
-35.0%
Q1 25
-3.5%
-21.6%
Q4 24
-14.8%
Q3 24
-14.6%
-17.9%
Q2 24
-17.4%
Q1 24
-30.8%
EPS (diluted)
HCWC
HCWC
RXST
RXST
Q4 25
$-0.05
$-0.22
Q3 25
$-0.09
$-0.24
Q2 25
$-0.03
$-0.29
Q1 25
$-0.07
$-0.20
Q4 24
$-0.14
Q3 24
$-0.29
$-0.16
Q2 24
$-0.16
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCWC
HCWC
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$3.0M
$228.1M
Total DebtLower is stronger
$7.3M
Stockholders' EquityBook value
$7.3M
$275.7M
Total Assets
$33.5M
$311.8M
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCWC
HCWC
RXST
RXST
Q4 25
$3.0M
$228.1M
Q3 25
$3.0M
$227.5M
Q2 25
$4.7M
$227.5M
Q1 25
$1.8M
$229.3M
Q4 24
$237.2M
Q3 24
$1.8M
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Total Debt
HCWC
HCWC
RXST
RXST
Q4 25
$7.3M
Q3 25
$8.5M
Q2 25
$9.7M
Q1 25
$10.6M
Q4 24
Q3 24
$11.6M
Q2 24
Q1 24
Stockholders' Equity
HCWC
HCWC
RXST
RXST
Q4 25
$7.3M
$275.7M
Q3 25
$5.9M
$276.0M
Q2 25
$5.8M
$278.0M
Q1 25
$2.1M
$279.3M
Q4 24
$281.2M
Q3 24
$2.9M
$277.3M
Q2 24
$275.2M
Q1 24
$163.9M
Total Assets
HCWC
HCWC
RXST
RXST
Q4 25
$33.5M
$311.8M
Q3 25
$33.7M
$308.5M
Q2 25
$36.4M
$309.0M
Q1 25
$34.1M
$313.0M
Q4 24
$318.6M
Q3 24
$33.2M
$310.5M
Q2 24
$305.5M
Q1 24
$183.2M
Debt / Equity
HCWC
HCWC
RXST
RXST
Q4 25
1.00×
Q3 25
1.43×
Q2 25
1.69×
Q1 25
5.01×
Q4 24
Q3 24
3.95×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCWC
HCWC
RXST
RXST
Operating Cash FlowLast quarter
$-855.1K
$-1.1M
Free Cash FlowOCF − Capex
$-927.1K
$-2.3M
FCF MarginFCF / Revenue
-5.0%
-6.9%
Capex IntensityCapex / Revenue
0.4%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$675.4K
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCWC
HCWC
RXST
RXST
Q4 25
$-855.1K
$-1.1M
Q3 25
$-308.7K
$-1.2M
Q2 25
$1.1M
$-4.4M
Q1 25
$1.1M
$-8.8M
Q4 24
$-4.3M
Q3 24
$650.0K
Q2 24
$-4.0M
Q1 24
$-9.3M
Free Cash Flow
HCWC
HCWC
RXST
RXST
Q4 25
$-927.1K
$-2.3M
Q3 25
$-351.3K
$-1.8M
Q2 25
$988.6K
$-5.9M
Q1 25
$965.3K
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
HCWC
HCWC
RXST
RXST
Q4 25
-5.0%
-6.9%
Q3 25
-1.8%
-5.8%
Q2 25
4.9%
-17.6%
Q1 25
4.8%
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
HCWC
HCWC
RXST
RXST
Q4 25
0.4%
3.5%
Q3 25
0.2%
1.9%
Q2 25
0.4%
4.6%
Q1 25
0.6%
1.5%
Q4 24
2.1%
Q3 24
3.1%
Q2 24
4.4%
Q1 24
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCWC
HCWC

Retail Grocery$17.1M91%
Food Service Restaurant$1.7M9%

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons